Stock Investing - StockBaggers.com

Leading Publishers Stay in Stock on Amazon.com with BookSurge’s Print on Demand Service (Business Wire)NEW YORK—-BookSurge LLC, a subsidiary of Amazon.com, Inc. , today announced agreements with major publishers to use BookSurge’s Print on Demand service to make their current, backlist, out-of-print and large print books available to millions of customers on Amazon.com and through other distribution channels.

Apple Debuts Unprotected Songs Online (AP)Apple Inc.’s iTunes Store started selling thousands of songs without copy protection Wednesday, marking the trendsetting company’s latest coup and a model for what analysts say will likely become a pattern for online music sales.

Apple TV: Not Ready for Prime Time (BusinessWeek Online)The set-top box that syncs with a computer is simple to set up but doesn’t deliver the audiovisual quality or all the features consumers may want

Sector Snap: Online Content Providers (AP)Shares of online content providers were mixed Wednesday, as Apple Inc. jumped to a new high after the company began selling songs without copy protection on its online iTunes Store.

TiVo Posts First-Ever Quarterly Profit (AP)TiVo Inc. posted its first-ever quarterly profit Wednesday as it pared expenses and increased revenues. The pioneer of digital video recorders swung to a small profit even though its cumulative number of subscribers dipped slightly to 4.3 million in its fiscal first quarter.

EBay Buys StumbleUpon For $75 Million (SeekingAlpha)EBay said Wednesday it acquired StumbleUpon, a company that helps people discover and share online content, for $75 million. StumbleUpon 2.3 million members currently add over five million recommendations of websites, videos etc. a day; its user base is growing by 150% annually.

AMZN Stock Investing | Google Finance AMZN | Yahoo Finance AMZN

Syntax-Brillian Shares Plunge On Earnings Miss, News of Public Offering (SeekingAlpha)Following the closing bell Thursday, Syntax-Brillian Corp. reported it swung to a profit in its third quarter , and that it plans to publicly offer an additional $172 million worth of shares in an underwritten offering.

Japan: Best and Worst Performing ADRs Last Week and YTD (SeekingAlpha)Steven Towns submits: Japanese ADRs trading on the NYSE/NASDAQ recouped some of their losses from two weeks ago. Financial stocks were strong, signaling a possible bottoming out, led by a 10-plus percent move to the upside by Mizuho FG .

Technology shares lift Tokyo market (FT.com)Japanese shares closed higher on Thursday morning trading after global markets largely shrugged off Wednesday’s 6.5 per cent fall on the Chinese stock market. The Nikkei 225 rose 1.1 per cent to finish the morning at 17,781.41 while the broader Topix index gained 0.85 per cent to reach 1,748.44.

MC Stock Investing | Google Finance MC | Yahoo Finance MC

Sector Glance: Biotechnology Ends Lower (AP)Biotechnology stocks followed the market lower Thursday, falling in a session light on industry news. The overall market fell, after positive housing data quelled hopes for an interest rate cut aimed at stimulating the economy.

Gilead Sees Positive Study Results (AP)Biopharmaceutical company Gilead Sciences Inc. said late Tuesday a late-stage study of its inhalable cystic fibrosis treatment candidate met its goal.

Jim Cramer’s Wall Street Confidential Picks, May 29 (SeekingAlpha)Miriam Metzinger submits: Recap of Jim Cramers comments on Wall Street Confidential, Tuesday May 29. Click on a stock ticker for more analysis: Celgene , Amgen , Genentech , Genzyme and Gilead Sciences , Northfield Laboratories , Onyx Pharmaceuticals , Cephalon Cramer said for every biotech stock like Celgene, there are a [.]

Sector Glance: Biotech Stocks End Higher (AP)Biotechnology stocks closed mostly higher Tuesday, amid some acquisition news in the sector, as Wall Street eked out a modest gain.

Ahead of the Bell: Auxilium (AP)A scar tissue treatment candidate could bring Auxilium Pharmaceuticals Inc. $800 million, a Banc of America analyst said Thursday, initiating coverage on the company’s stock with a “Buy” rating and initiating coverage on several other biotechs.

Jim Cramer’s Mad Money Lightning Round Picks, May 23 (SeekingAlpha)Miriam Metzinger submits: Stocks discussed in the lightning round session of Jim Cramers Mad Money TV program, Wednesday May 23 Click on a stock ticker for more analysis: Bullish calls: Gilead Sciences :’ . at $81 - a nice little pullback.’ Celgene : ‘ . has not only not let us down, but now has a [.]

GILD Stock Investing | Google Finance GILD | Yahoo Finance GILD

Diabetes expert warned FDA about Avandia in 2000 (at CNNMoney.com)President of American Diabetes Association warned the FDA about Glaxo drug’s heart risk seven years before high-profile Avandia study.

Nasdaq 100 Leaders & Laggards: AMZN,YHOO (AP)Shares of Amazon.com hit a seven-year high helping lift the Nasdaq 100 on Monday. The Nasdaq 100, which includes 100 of the largest nonfinancial securities traded on the Nasdaq Stock Market, added 8.91 to 1911.16.

Nasdaq 100 Leaders & Laggards: PETM AMAT (AP)The Nasdaq 100 finished lower Monday, after Petsmart Inc. shares fell on an analyst’s downgrade. The Nasdaq 100, which includes 100 of the largest nonfinancial securities traded on the Nasdaq Stock Market, shed 10.71 points to 1,888.08.

Amylin CEO Sells Shares (AP)The president and chief executive of biotech drug maker Amylin Pharmaceuticals Inc. sold 2,894 shares of common stock under a prearranged trading plan, according to a Securities and Exchange Commission filing Wednesday.

AMLN Stock Investing | Google Finance AMLN | Yahoo Finance AMLN

Arithmatica names new CEO (bizjournals.com)Arithmatica Inc. on Tuesday named Dan Ganousis chief executive.

Stock Investing | Google Finance XLNX | Yahoo Finance XLNX

Amgen Oncology Highlights Upcoming Data Presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting (Business Wire)THOUSAND OAKS, Calif.—-Amgen , today announced upcoming data presentations of interest at the 43rd Annual American Society of Clinical Oncology Meeting in Chicago.

Cancer Drugs in Focus at Doctor Meeting (AP)Pfizer Inc. and Bristol-Myers Squibb Co. hope to introduce cancer treatments that could help the drug giants regain their footing, and a medical conference beginning Friday may show if they’re on the right path.

Amgen: Still A Bargain Despite New Warning Labels, Recent Selloff (SeekingAlpha)Alex Garcia submits: An FDA panel recommended stronger warning labels and further clinical studies on Amgens Arenesp drug and Johnson and Johnsons Procrit drugs. In typical Wall Street fashion, shares of Amgen sold off on the recommendations.

Cancer Stocks on the Go: Winners and Losers (SeekingAlpha)Alan Brochstein, CFA submits: Later this week, the big event of the year for companies trying to treat cancer takes place in Chicago: the American Society of Clinical Oncologys Annual Meeting.

AMGN Stock Investing | Google Finance AMGN | Yahoo Finance AMGN